Lifeloc Technologies Q3 net loss narrows as margin improves
LCTC•
LCTC•Lifeloc Technologies reported a third-quarter net loss of $85,000, with gross margin improving to 43% from 40%. The company delayed the limited commercial launch of its SpinDetect analyzer to Q4 2027 from Q1 2027.
Lifeloc Technologies’ third-quarter net loss narrowed, while gross margin rose to 43% from 40%. The company attributed the margin improvement to price increases and favorable product mix; net loss was $85,000 and loss per share was $0.03.
Lifeloc now expects a limited commercial launch of its SpinDetect analyzer in Q4 2027, delayed from Q1 2027. Elevated research and development spending, mainly for SpinDetect, contributed to the quarterly loss. The company is redirecting engineering resources toward upgrades to core alcohol testing products to generate incremental revenue and fund SpinDetect development.